Special Podcast Episode: Fifth Annual Policy Summit Highlights with Emily Walsh, PhD
Watch on demand through Oct. 23 - September 25, 2023
Emily Walsh, PhD, principal at Tremont Therapeutics Consulting, discussed what happened at this year’s Policy Summit—and why it was a big deal. Chris Leidli, member of ASGCT’s Communications Committee, hosted. Register for the Policy Summit today to watch sessions on demand until Oct. 23!
.png)
Emily Walsh, PhD, at Tremont Therapeutics Consulting, works with gene and cell therapy companies and investors who are seeking to advance novel therapies in the clinic. ASGCT’s Policy Summit is a big deal to her: It provides a full view of the clinical pipeline and helps her guide clients past the drug approval process and into considerations of patient access, manufacturing, and reimbursement.
In this podcast episode, Dr. Walsh shared her highlights and thoughts on the Summit—now on demand until Oct. 23 with its highest-profile speaker line-up yet. Her interviewer was Chris Leidli, host of the Rx for Biotech podcast and member of ASGCT’s Communications Committee.
Hear Dr. Walsh discuss meeting top CGT decision makers, patients, and advocates in the same room; the session on the recent CGT Access Model from the Centers for Medicare and Medicaid Innovation (with deputy director Laura McWright); and, of course, the first in-person speaking engagement of Nicole Verdun, MD, director of FDA CBER’s new Office of Therapeutic Products (OTP). Dr. Walsh also shared her thoughts on patient-focused development, public access to data, and FDA’s support of platform designations for new CGT treatments.
This year’s Policy Summit is still available to view on-demand until October 23! Learn more at asgct.org/advocacy/policy-summit.
Not sure if on-demand access is worth it? Let Dr. Walsh convince you why you don’t want to miss this year’s event!
ASGCT's Policy Summit connects you with policy and industry leaders in the field where you'll learn from a variety of stakeholder perspectives and how they inform regulatory, legislative, and payment policies that impact gene and cell therapy development. Register now to view all sessions on demand until Oct. 23.
You can subscribe to the ASGCT channel wherever you listen to your podcasts (including Apple, Spotify, Overcast, Pocket Casts, and more).
Search “ASGCT” in your podcast app to subscribe to the ASGCT Podcast Network
Related Articles